New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer
Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine…
After Nearly 4 Decades of Research, W.K. Alfred Yung, MD, Sees a New Era Ahead for Advances in Brain Tumors
After he was not accepted into the University of Hong Kong, plan B for W.K. Alfred Yung, MD, was to leave his country and immigrate to the United States to attend the University of Minnesota in Minneapolis—a move he considers…
Using rooom to Build a Community
Together with the National Foundation for Cancer Research (NFCR) and the AIM-HI Accelerator Fund (AIM-HI) we hosted a charitable hybrid combo event on October 30 2021 – our first big project in the United States. While the live event took place at…
Strategic Media Partner
